title: Review: Long-term dual-antiplatelet therapy (DAPT) after PCI is no better than short-term DAPT, even with diabetes.
authors.affiliation: Washington University School of MedicineSt. Louis, Missouri, USA.
authors.forename: Richard G
authors.initials: RG
authors.lastname: Bach
mesh_terms: D003920:Diabetes Mellitus; D006801:Humans; D062645:Percutaneous Coronary Intervention; D010975:Platelet Aggregation Inhibitors
chemical_list: D010975:Platelet Aggregation Inhibitors